Dr. Reddy's Laboratories Limited
RDY
$12.70
-$0.21-1.63%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 989.56M | 957.01M | 919.78M | 852.97M | 866.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 989.56M | 957.01M | 919.78M | 852.97M | 866.74M |
| Cost of Revenue | 408.84M | 386.72M | 364.22M | 353.41M | 359.74M |
| Gross Profit | 580.72M | 570.29M | 555.56M | 499.56M | 507.00M |
| SG&A Expenses | 285.52M | 274.67M | 272.01M | 246.58M | 243.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.10M | -6.61M | -5.43M | -8.09M | -5.96M |
| Total Operating Expenses | 768.08M | 741.58M | 705.04M | 674.72M | 663.64M |
| Operating Income | 221.48M | 215.43M | 214.73M | 178.25M | 203.10M |
| Income Before Tax | 221.88M | 228.82M | 225.62M | 192.87M | 219.33M |
| Income Tax Expenses | 55.69M | 68.67M | 58.75M | 35.48M | 53.68M |
| Earnings from Continuing Operations | 166.19M | 160.15M | 166.87M | 157.40M | 165.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.12M | -10.29M | -- | -- | -- |
| Net Income | 167.32M | 149.86M | 166.87M | 157.40M | 165.65M |
| EBIT | 221.48M | 215.43M | 214.73M | 178.25M | 203.10M |
| EBITDA | 277.35M | 262.88M | 260.41M | 209.20M | 248.39M |
| EPS Basic | 0.20 | 0.18 | 0.20 | 0.19 | 0.20 |
| Normalized Basic EPS | 0.17 | 0.16 | 0.16 | 0.14 | 0.16 |
| EPS Diluted | 0.20 | 0.18 | 0.20 | 0.19 | 0.20 |
| Normalized Diluted EPS | 0.17 | 0.16 | 0.16 | 0.14 | 0.16 |
| Average Basic Shares Outstanding | 833.31M | 832.98M | 832.64M | 832.59M | 832.67M |
| Average Diluted Shares Outstanding | 834.30M | 834.09M | 833.93M | 834.08M | 833.68M |
| Dividend Per Share | -- | -- | -- | 0.10 | -- |
| Payout Ratio | 0.00% | 53.07% | -- | 0.00% | 0.00% |
